Bone marrow immunophenotyping by flow cytometry in refractory cytopenia of childhood

Refractory cytopenia of childhood is the most common type of childhood myelodysplastic syndrome. Because the majority of children with refractory cytopenia have a normal karyotype and a hypocellular bone marrow, differentiating refractory cytopenia from the immune-mediated bone marrow failure syndrome (very) severe aplastic anemia can be challenging. Flow cytometric immunophenotyping of bone marrow has been shown to be a valuable diagnostic tool in differentiating myelodysplastic syndrome from non-clonal cytopenias in adults. Here, we performed the first comprehensive flow cytometric analysis of immature myeloid, lymphoid cells and erythroid cells, and granulocytes, monocytes, and lymphoid cells in bone marrow obtained from a large prospective cohort of 81 children with refractory cytopenia. Children with refractory cyotopenia had a strongly reduced myeloid compartment, but not as severe as children with aplastic anemia. Furthermore, the number of flow cytometric abnormalities was significantly higher in children with refractory cytopenia than in healthy controls and in children with aplastic anemia, but lower than in advanced myelodysplastic syndrome. We conclude that flow cytometric immunophenotyping could be a relevant addition to histopathology in the diagnosis of refractory cytopenia of childhood. (The multi-center studies EWOG-MDS RC06 and EWOG-MDS 2006 are registered at clinicaltrials.gov identifiers 00499070 and 00662090, respectively).

[1]  R. Pieters,et al.  T-cell receptor Vβ skewing frequently occurs in refractory cytopenia of childhood and is associated with an expansion of effector cytotoxic T cells: a prospective study by EWOG-MDS , 2014, Blood Cancer Journal.

[2]  P. de Paepe,et al.  Comparison of horse and rabbit antithymocyte globulin in immunosuppressive therapy for refractory cytopenia of childhood , 2014, Haematologica.

[3]  F. Locatelli,et al.  Applicability of a reproducible flow cytometry scoring system in the diagnosis of refractory cytopenia of childhood , 2013, Leukemia.

[4]  M. Béné,et al.  Flow cytometric detection of dyserythropoiesis: a sensitive and powerful diagnostic tool for myelodysplastic syndromes , 2013, Leukemia.

[5]  J. te Marvelde,et al.  No significant prognostic value of normal precursor B‐cell regeneration in paediatric acute myeloid leukaemia after induction treatment , 2013, British journal of haematology.

[6]  P. Rohrlich,et al.  High frequency of GATA2 mutations in patients with mild chronic neutropenia evolving to MonoMac syndrome, myelodysplasia, and acute myeloid leukemia. , 2013, Blood.

[7]  T. Naoe,et al.  Differences in blast immunophenotypes among disease types in myelodysplastic syndromes: a multicenter validation study. , 2012, Leukemia research.

[8]  T. Kalina,et al.  EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols , 2012, Leukemia.

[9]  C. Pascutto,et al.  Multicenter validation of a reproducible flow cytometric score for the diagnosis of low-grade myelodysplastic syndromes: results of a European LeukemiaNET study , 2012, Haematologica.

[10]  P. de Paepe,et al.  Morphological differentiation of severe aplastic anaemia from hypocellular refractory cytopenia of childhood: reproducibility of histopathological diagnostic criteria , 2012, Histopathology.

[11]  A. Órfão,et al.  Altered immunophenotypic features of peripheral blood platelets in myelodysplastic syndromes , 2012, Haematologica.

[12]  A Orfao,et al.  EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes , 2012, Leukemia.

[13]  A. Órfão,et al.  Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group , 2012, Leukemia.

[14]  I. Baumann,et al.  Classification of childhood aplastic anemia and myelodysplastic syndrome. , 2011, Hematology. American Society of Hematology. Education Program.

[15]  E. Mejstrikova,et al.  Changes Identified by Flow Cytometry and WT1 Expression in Consecutive Bone Marrow Samples in Refractory Cytopenia of Childhood and Aplastic Anemia Before Start of the Therapy , 2011 .

[16]  Sahar Mansour,et al.  Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome) , 2011, Nature Genetics.

[17]  Bernard Keavney,et al.  Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency. , 2011, Blood.

[18]  Smita Y. Patel,et al.  Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome. , 2011, Blood.

[19]  A. Dutra,et al.  Myelodysplasia in autosomal dominant and sporadic monocytopenia immunodeficiency syndrome: diagnostic features and clinical implications , 2011, Haematologica.

[20]  Anna L. Brown,et al.  Heritable GATA2 Mutations Associated with Familial Myelodysplastic Syndrome and Acute Myeloid Leukemia , 2011, Nature Genetics.

[21]  T. Haferlach,et al.  Clinical utility of multiparameter flow cytometry in the diagnosis of 1013 patients with suspected myelodysplastic syndrome , 2010, Cancer.

[22]  J. Hernández-Rivas,et al.  Bone marrow cells from myelodysplastic syndromes show altered immunophenotypic profiles that may contribute to the diagnosis and prognostic stratification of the disease: A pilot study on a series of 56 patients , 2010, Cytometry. Part B, Clinical cytometry.

[23]  G. Ossenkoppele,et al.  Aberrant immunophenotype of blasts in myelodysplastic syndromes is a clinically relevant biomarker in predicting response to growth factor treatment. , 2010, Blood.

[24]  Adeline R. Whitney,et al.  Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia. , 2010, Blood.

[25]  S. Fenu,et al.  Advanced pediatric myelodysplastic syndromes: Can immunophenotypic characterization of blast cells be a diagnostic and prognostic tool? , 2009, Pediatric blood & cancer.

[26]  J. Gratama,et al.  Flow cytometric differential of leukocyte populations in normal bone marrow: Influence of peripheral blood contamination1 , 2009, Cytometry. Part B, Clinical cytometry.

[27]  M. Loken,et al.  Normalization of bone marrow aspirates for hemodilution in flow cytometric analyses , 2009, Cytometry. Part B, Clinical cytometry.

[28]  John Barrett,et al.  Factors affecting response and survival in patients with myelodysplasia treated with immunosuppressive therapy. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  A. Órfão,et al.  The immunophenotype of different immature, myeloid and B-cell lineage-committed CD34+ hematopoietic cells allows discrimination between normal/reactive and myelodysplastic syndrome precursors , 2008, Leukemia.

[30]  R. Pieters,et al.  T-cell receptor Vβ CDR3 oligoclonality frequently occurs in childhood refractory cytopenia (MDS-RC) and severe aplastic anemia , 2008, Leukemia.

[31]  V. V. D. van der Velden,et al.  Identification of distinct prognostic subgroups in low- and intermediate-1-risk myelodysplastic syndromes by flow cytometry. , 2008, Blood.

[32]  K. Metze,et al.  The prognostic value of maturation-associated phenotypic abnormalities in myelodysplastic syndromes. , 2008, Leukemia research.

[33]  F. Locatelli,et al.  Reduced intensity conditioning in unrelated donor transplantation for refractory cytopenia in childhood , 2007, Bone Marrow Transplantation.

[34]  H. Tamura,et al.  Diagnostic application of flow cytometric characteristics of CD34+ cells in low-grade myelodysplastic syndromes. , 2006, Blood.

[35]  M. Cazzola,et al.  Flow cytometry evaluation of erythroid dysplasia in patients with myelodysplastic syndrome , 2006, Leukemia.

[36]  W. Friedrich,et al.  Immunosuppressive therapy for aplastic anemia in children: a more severe disease predicts better survival. , 2005, Blood.

[37]  M. Cazzola,et al.  Flow cytometry evaluation of erythroid and myeloid dysplasia in patients with myelodysplastic syndrome , 2005, Leukemia.

[38]  M. Cazzola,et al.  Flow Cytometry Evaluation of Erythroid Dysplasia in Patients with Myelodysplastic Syndrome. , 2004 .

[39]  H. Deeg,et al.  Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after hematopoietic stem cell transplantation. , 2003, Blood.

[40]  C. Stiller,et al.  Paediatric myelodysplastic syndromes and juvenile myelomonocytic leukaemia in the UK: a population‐based study of incidence and survival , 2003, British journal of haematology.

[41]  T. Chuhjo,et al.  Clinical significance of a minor population of paroxysmal nocturnal hemoglobinuria-type cells in bone marrow failure syndrome. , 2002, Blood.

[42]  Yvan Cornet,et al.  Immunophenotypic clustering of myelodysplastic syndromes. , 2002, Blood.

[43]  D. Follmann,et al.  Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH/aplastic anemia syndrome. , 2001, Blood.

[44]  D C Arthur,et al.  Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome. , 2001, Blood.

[45]  M. McBride,et al.  A population‐based study of childhood myelodysplastic syndrome in British Columbia, Canada , 1999, British journal of haematology.

[46]  F. Miélot.  Childhood myelodysplastic syndromes. , 1999, Pediatric hematology and oncology.

[47]  H. Hasle,et al.  Childhood myelodysplastic syndrome in Denmark: incidence and predisposing conditions. , 1995, Leukemia.

[48]  R. Pieters,et al.  The clinical relevance of minor paroxysmal nocturnal hemoglobinuria clones in refractory cytopenia of childhood: a prospective study by EWOG-MDS , 2014, Leukemia.

[49]  P. Rohrlich,et al.  High frequency of GATA 2 mutations in patients with mild chronic neutropenia evolving to MonoMac syndrome , myelodysplasia , and acute myeloid leukemia * , 2013 .

[50]  H. G. van Eijk,et al.  The expression of transferrin receptors on erythroblasts in anaemia of chronic disease, myelodysplastic syndromes and iron deficiency. , 1997, Acta haematologica.

[51]  C. Haanen,et al.  A method for quantification of peripheral blood admixture in bone marrow aspirates. , 1980, Experimental hematology.